According to Li et al., TIM-3 expression was higher on CD4+ and CD8+ T cells in HBV-associated HCC compared to the surrounding tissues, and the proportion of TIM-3+ tumor-infiltrating lymphocytes was inversely related to patient survival [15]. The gene discussed is HAVCR2; the disease is hepatocellular carcinoma.